Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is a highly aggressive disease. It is marked by a lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Thus, treating TNBC patients with targeted therapy and having a biomarker for therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Priyanka P., Narra, Kalyani, James, Johanna D., Jones, Harlan P., Tripathi, Amit K., Vishwanatha, Jamboor K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818227/
https://www.ncbi.nlm.nih.gov/pubmed/36612209
http://dx.doi.org/10.3390/cancers15010212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818227/
https://www.ncbi.nlm.nih.gov/pubmed/36612209
http://dx.doi.org/10.3390/cancers15010212

Ejemplares similares